Trial intelligence / Profile preview

Phase 2 study of azacitidine for molecular relapse of pediatric acute myeloid leukemia

2017-003422-32Phase 2Completed

Sponsor

German Society for Pediatric Oncology and Hematology

Start

Nov 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1